Back to search

Article

Utilisation of semiconductor sequencing for detection of actionable fusions in solid tumours

2021-01-27

Abstract excerpt

Oncogenic fusions represent compelling druggable targets in solid tumours highlighted by the recent site agnostic FDA approval of larotrectinib for NTRK rearrangements. However screening for fusions in routinely processed tissue samples is constrained due to degradation of nucleic acid as a result of formalin fixation., To investigate the clinical utility of semiconductor sequencing optimised for detection of acti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
70410186-b781-5d90-a9d7-ea2580dbfa8a
DOI
10.1101/2021.01.27.428383
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Utilisation of semiconductor sequencing for detection of actionable fusions in solid tumoursDOI 10.1101/2021.01.27.428383
Select a neighboring publication to make it the new centre.